Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
about
Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data.Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor.Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review.Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism.
P2860
Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Association between the use of ...... evation myocardial infarction.
@en
type
label
Association between the use of ...... evation myocardial infarction.
@en
prefLabel
Association between the use of ...... evation myocardial infarction.
@en
P2093
P50
P356
P1476
Association between the use of ...... evation myocardial infarction.
@en
P2093
Jonas Oldgren
Jonas Spaak
Karolina Szummer
Lars Lindhagen
Stefan H Jacobson
Tomas Jernberg
P304
P356
10.1001/JAMA.2015.517
P407
P577
2015-02-01T00:00:00Z